Coronary revascularization in diabetic patients. A focus on the 3-year SYNTAX trial outcomes

Herz

Volumn 37, Issue 3, 2012, Pages 281-286

  Groot, M W ^a   Head, S J ^a   Bogers, Ad J J C ^a   Kappetein, A P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery bypass grafting; Diabetes mellitus; Percutaneous coronary intervention; Revascularization; Stents

Indexed keywords

ARTICLE; BARE METAL STENT; CAROTID ANGIOPLASTY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SURVIVAL RATE;

COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; HUMANS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TEXAS; TREATMENT OUTCOME;

EID: 84863093989     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-012-3602-4     Document Type: Article

References (27)

1. Li YW, Aronow WS (2011) Diabetes mellitus and cardiovascular disease. J Clin Exp Cardiolog 2: 114. doi: 10.4172/2155-9880.1000114
2. Fox CS, Coady S, Sorlie PD et al (2004) Trends in cardiovascular complications of diabetes. JAMA 292: 2495-2499 (Pubitemid 39552675)
3. Preis SR, Hwang SJ, Coady S et al (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham heart study, 1950-2005. Circulation 119: 1728-1735
4. Soares PR, Hueb WA, Lemos PA et al (2006) Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II). Circulation 114: I420-I424 (Pubitemid 44297185)
5. Group BDS, Frye RL, August P et al (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360: 2503-2515
6. Maron DJ, Boden WE, Spertus JA et al (2011) Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. J Am Coll Cardiol 58: 131-137
7. Investigators B (2007) The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 49: 1600-1606
8. Detre KM, Guo P, Holubkov R et al (1999) Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 99: 633-640 (Pubitemid 29077362)
9. King SB 3rd, Kosinski AS, Guyton RA et al (2000) Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol 35: 1116-1121 (Pubitemid 30206883)
10. Kurbaan AS, Bowker TJ, Ilsley CD et al (2001) Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. Am J Cardiol 87: 947-950; A943 (Pubitemid 32299976)
11. Henderson RA, Pocock SJ, Sharp SJ et al (1998) Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet 352: 1419-1425 (Pubitemid 28510875)
12. Van Belle E, Abolmaali K, Bauters C et al (1999) Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. J Am Coll Cardiol 34: 476-485
13. Serruys PW, Jaegere P de, Kiemeneij F et al (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331: 489-495 (Pubitemid 24256751)
14. Fischman DL, Leon MB, Baim DS et al (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331: 496-501 (Pubitemid 24256752)
15. Daemen J, Boersma E, Flather M et al (2008) Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 118: 1146-1154
16. Rodriguez AE, Baldi J, Fernandez Pereira C et al (2005) Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 46: 582-588 (Pubitemid 41132681)
17. Booth J, Clayton T, Pepper J et al (2008) Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 118: 381-388
18. Serruys PW, Ong AT, Herwerden LA van et al (2005) Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46: 575-581 (Pubitemid 41132680)
19. Hlatky MA, Boothroyd DB, Bravata DM et al (2009) Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 373: 1190-1197
20. Flaherty JD, Davidson CJ (2005) Diabetes and coronary revascularization. JAMA 293: 1501-1508 (Pubitemid 40393296)
21. Kapur A, Hall RJ, Malik IS et al (2010) Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 55: 432-440
22. Mack MJ, Banning AP, Serruys PW et al (2011) Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. Ann Thorac Surg 92: 2140-2146
23. Banning AP, Westaby S, Morice MC et al (2010) Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 55: 1067-1075
24. Sianos G, Morel MA, Kappetein AP et al (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1: 219-227
25. Kaehler J, Koester R, Billmann W et al (2005) 13-year follow-up of the German angioplasty bypass surgery investigation. Eur Heart J 26: 2148-2153 (Pubitemid 41407998)
26. Sedlis SP, Morrison DA, Lorin JD et al (2002) Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol 40: 1555-1566 (Pubitemid 35253632)
27. Farkouh ME, Dangas G, Leon MB et al (2008) Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial. Am Heart J 155: 215-233